Cargando…
High-Quality Masks Reduce COVID-19 Infections and Deaths in the US
OBJECTIVES: To evaluate the effectiveness of widespread adoption of masks or face coverings to reduce community transmission of the SARS-CoV-2 virus that causes COVID-19. METHODS: We created an agent-based stochastic network simulation using a variant of the standard SEIR dynamic infectious disease...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852241/ https://www.ncbi.nlm.nih.gov/pubmed/33532790 http://dx.doi.org/10.1101/2020.09.27.20199737 |
_version_ | 1783645783643389952 |
---|---|
author | Rosenstrom, Erik Oruc, Buse Eylul Hupert, Nathaniel Ivy, Julie Keskinocak, Pinar Mayorga, Maria E. Swann, Julie L. |
author_facet | Rosenstrom, Erik Oruc, Buse Eylul Hupert, Nathaniel Ivy, Julie Keskinocak, Pinar Mayorga, Maria E. Swann, Julie L. |
author_sort | Rosenstrom, Erik |
collection | PubMed |
description | OBJECTIVES: To evaluate the effectiveness of widespread adoption of masks or face coverings to reduce community transmission of the SARS-CoV-2 virus that causes COVID-19. METHODS: We created an agent-based stochastic network simulation using a variant of the standard SEIR dynamic infectious disease model. We considered a mask order that was initiated 3.5 months after the first confirmed COVID-19 case. We varied the likelihood of individuals wearing masks from 0–100% in steps of 20% (mask adherence) and considered 25% to 90% mask-related reduction in viral transmission (mask efficacy). Sensitivity analyses assessed early (by week 13) versus late (by week 42) adoption of masks and geographic differences in adherence (highest in urban and lowest in rural areas). RESULTS: Introduction of mask use with 50% efficacy worn by 50% of individuals reduces the cumulative infection attack rate (IAR) by 27%, the peak prevalence by 49%, and population-wide mortality by 29%. If 90% of individuals wear 50% efficacious masks, this decreases IAR by 54%, peak prevalence by 75%, and population-wide mortality by 55%; similar improvements hold if 70% of individuals wear 75% efficacious masks. Late adoption reduces IAR and deaths by 18% or more compared to no adoption. Lower adoption in rural areas than urban would lead to rural areas having the highest IAR. CONCLUSIONS: Even after community transmission of SARS-CoV-2 has been established, adoption of mask-wearing by a majority of community-dwelling individuals can meaningfully reduce the number and outcome of COVID-19 infections over and above physical distancing interventions. |
format | Online Article Text |
id | pubmed-7852241 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-78522412021-02-03 High-Quality Masks Reduce COVID-19 Infections and Deaths in the US Rosenstrom, Erik Oruc, Buse Eylul Hupert, Nathaniel Ivy, Julie Keskinocak, Pinar Mayorga, Maria E. Swann, Julie L. medRxiv Article OBJECTIVES: To evaluate the effectiveness of widespread adoption of masks or face coverings to reduce community transmission of the SARS-CoV-2 virus that causes COVID-19. METHODS: We created an agent-based stochastic network simulation using a variant of the standard SEIR dynamic infectious disease model. We considered a mask order that was initiated 3.5 months after the first confirmed COVID-19 case. We varied the likelihood of individuals wearing masks from 0–100% in steps of 20% (mask adherence) and considered 25% to 90% mask-related reduction in viral transmission (mask efficacy). Sensitivity analyses assessed early (by week 13) versus late (by week 42) adoption of masks and geographic differences in adherence (highest in urban and lowest in rural areas). RESULTS: Introduction of mask use with 50% efficacy worn by 50% of individuals reduces the cumulative infection attack rate (IAR) by 27%, the peak prevalence by 49%, and population-wide mortality by 29%. If 90% of individuals wear 50% efficacious masks, this decreases IAR by 54%, peak prevalence by 75%, and population-wide mortality by 55%; similar improvements hold if 70% of individuals wear 75% efficacious masks. Late adoption reduces IAR and deaths by 18% or more compared to no adoption. Lower adoption in rural areas than urban would lead to rural areas having the highest IAR. CONCLUSIONS: Even after community transmission of SARS-CoV-2 has been established, adoption of mask-wearing by a majority of community-dwelling individuals can meaningfully reduce the number and outcome of COVID-19 infections over and above physical distancing interventions. Cold Spring Harbor Laboratory 2021-01-28 /pmc/articles/PMC7852241/ /pubmed/33532790 http://dx.doi.org/10.1101/2020.09.27.20199737 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator. |
spellingShingle | Article Rosenstrom, Erik Oruc, Buse Eylul Hupert, Nathaniel Ivy, Julie Keskinocak, Pinar Mayorga, Maria E. Swann, Julie L. High-Quality Masks Reduce COVID-19 Infections and Deaths in the US |
title | High-Quality Masks Reduce COVID-19 Infections and Deaths in the US |
title_full | High-Quality Masks Reduce COVID-19 Infections and Deaths in the US |
title_fullStr | High-Quality Masks Reduce COVID-19 Infections and Deaths in the US |
title_full_unstemmed | High-Quality Masks Reduce COVID-19 Infections and Deaths in the US |
title_short | High-Quality Masks Reduce COVID-19 Infections and Deaths in the US |
title_sort | high-quality masks reduce covid-19 infections and deaths in the us |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852241/ https://www.ncbi.nlm.nih.gov/pubmed/33532790 http://dx.doi.org/10.1101/2020.09.27.20199737 |
work_keys_str_mv | AT rosenstromerik highqualitymasksreducecovid19infectionsanddeathsintheus AT orucbuseeylul highqualitymasksreducecovid19infectionsanddeathsintheus AT hupertnathaniel highqualitymasksreducecovid19infectionsanddeathsintheus AT ivyjulie highqualitymasksreducecovid19infectionsanddeathsintheus AT keskinocakpinar highqualitymasksreducecovid19infectionsanddeathsintheus AT mayorgamariae highqualitymasksreducecovid19infectionsanddeathsintheus AT swannjuliel highqualitymasksreducecovid19infectionsanddeathsintheus |